182 related articles for article (PubMed ID: 32598699)
1. [Clinical efficacy of mechanical bacterial lysate in the prevention of infectious exacerbations of chronic obstructive pulmonary disease].
Avdeev SN; Nuralieva GS; Gainitdinova VV; Baimakanova GE; So AK; Merzhoeva ZM
Ter Arkh; 2020 May; 92(4):57-63. PubMed ID: 32598699
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
3. Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation).
Braido F; Melioli G; Cazzola M; Fabbri L; Blasi F; Moretta L; Canonica GW;
Pulm Pharmacol Ther; 2015 Aug; 33():75-80. PubMed ID: 25951945
[TBL] [Abstract][Full Text] [Related]
4. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
6. [Acute exacerbations of chronic obstructive pulmonary disease].
Chabot F; Gomez E; Guillaumot A; Kheir A; Chaouat A
Presse Med; 2009 Mar; 38(3):485-95. PubMed ID: 19185446
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
8. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
[TBL] [Abstract][Full Text] [Related]
9. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
10. Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone.
Cazzola M; Noschese P; Di Perna F
Ther Adv Respir Dis; 2009 Apr; 3(2):59-63. PubMed ID: 19443519
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
12. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
[TBL] [Abstract][Full Text] [Related]
13. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.
Murphy TF; Sethi S
Drugs Aging; 2002; 19(10):761-75. PubMed ID: 12390053
[TBL] [Abstract][Full Text] [Related]
14. Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.
Krachunov I; Kyuchukov N; Ivanova Z; Yanev NA; Hristova PA; Pavlov P; Glogovska P; Popova T; Ivanov YY
Folia Med (Plovdiv); 2018 Dec; 60(4):536-545. PubMed ID: 31188775
[TBL] [Abstract][Full Text] [Related]
15. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
Uzun S; Djamin RS; Kluytmans JA; Mulder PG; van't Veer NE; Ermens AA; Pelle AJ; Hoogsteden HC; Aerts JG; van der Eerden MM
Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
[TBL] [Abstract][Full Text] [Related]
19. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
20. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Leuppi JD; Schuetz P; Bingisser R; Bodmer M; Briel M; Drescher T; Duerring U; Henzen C; Leibbrandt Y; Maier S; Miedinger D; Müller B; Scherr A; Schindler C; Stoeckli R; Viatte S; von Garnier C; Tamm M; Rutishauser J
JAMA; 2013 Jun; 309(21):2223-31. PubMed ID: 23695200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]